tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ADCT Stock Latest News

ADC Therapeutics: Strong Financials and Promising Trials Support Buy Rating
RatingsADC Therapeutics: Strong Financials and Promising Trials Support Buy Rating
7d ago
ADCT
ADC Therapeutics price target lowered to $7 from $10 at Guggenheim
PremiumThe Fly
ADC Therapeutics price target lowered to $7 from $10 at Guggenheim
7d ago
ADCT
ADC Therapeutics Earnings Call: Optimism Amid Challenges
PremiumCompany Announcements
ADC Therapeutics Earnings Call: Optimism Amid Challenges
10d ago
ADCT
ADC Therapeutics Reports Strong 2024 Financials and Trial Progress
PremiumCompany Announcements
ADC Therapeutics Reports Strong 2024 Financials and Trial Progress
10d ago
ADCT
Morning Movers: Nvidia slips following report of H20 chip shortage in China
PremiumThe Fly
Morning Movers: Nvidia slips following report of H20 chip shortage in China
11d ago
EQ
GME
ADC Therapeutics reports Q4 adjusted EPS (25c) vs. (97c) last year
PremiumThe FlyADC Therapeutics reports Q4 adjusted EPS (25c) vs. (97c) last year
11d ago
ADCT
ADCT Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ADCT Upcoming Earnings Report: What to Expect?
13d ago
ADCT
ADC Therapeutics price target raised to $8 from $6 at Stephens
Premium
The Fly
ADC Therapeutics price target raised to $8 from $6 at Stephens
1M ago
ADCT
ADC Therapeutics Achieves Profitability with ZYNLONTA
PremiumCompany Announcements
ADC Therapeutics Achieves Profitability with ZYNLONTA
3M ago
8K
ADCT
Closing Bell Movers: Inari adds 21% after confirmed Stryker buyout
PremiumThe Fly
Closing Bell Movers: Inari adds 21% after confirmed Stryker buyout
3M ago
SYK
ADCT
ADC Therapeutics completes enrollment in LOTIS-5 trial
PremiumThe Fly
ADC Therapeutics completes enrollment in LOTIS-5 trial
3M ago
ADCT
ADC Therapeutics falls -8.9%
PremiumThe Fly
ADC Therapeutics falls -8.9%
4M ago
ADCT
ADC Therapeutics announces data from LOTIS-7 Phase 1b open-label clinical trial
PremiumThe FlyADC Therapeutics announces data from LOTIS-7 Phase 1b open-label clinical trial
4M ago
ADCT
ADC Therapeutics: Updated data from Phase 2 Zynlonta study published in Lancet
Premium
The Fly
ADC Therapeutics: Updated data from Phase 2 Zynlonta study published in Lancet
4M ago
ADCT
Molson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
Premium
The Fly
Molson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
5M ago
HD
SG
ADC Therapeutics Highlights Q3 Advances and Strategic Focus
PremiumCompany Announcements
ADC Therapeutics Highlights Q3 Advances and Strategic Focus
5M ago
ADCT
ADC Therapeutics initiated with an Overweight at Stephens
PremiumThe Fly
ADC Therapeutics initiated with an Overweight at Stephens
5M ago
ADCT
ADC Therapeutics initiated with an Overweight at Stephens on Zynlonta potential
PremiumThe Fly
ADC Therapeutics initiated with an Overweight at Stephens on Zynlonta potential
5M ago
ADCT
ADC Therapeutics reports Q3 adjusted EPS (28c), consensus (39c)
PremiumThe Fly
ADC Therapeutics reports Q3 adjusted EPS (28c), consensus (39c)
5M ago
ADCT
ADC Therapeutics and the Perils of Outsourced Trials: Navigating the Uncertainty of ZYNLONTA’s Phase 2 Study
PremiumCompany AnnouncementsADC Therapeutics and the Perils of Outsourced Trials: Navigating the Uncertainty of ZYNLONTA’s Phase 2 Study
6M ago
ADCT
ADC Therapeutics files $300M mixed securities shelf
Premium
The Fly
ADC Therapeutics files $300M mixed securities shelf
8M ago
ADCT
ADC Therapeutics sees cash runway into mid-2026
Premium
The Fly
ADC Therapeutics sees cash runway into mid-2026
8M ago
ADCT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >